Tower Research Capital LLC (Trc) Ocugen, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in Ocugen, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 35 shares of OCGN stock, worth $41. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 72,776 99.95%
Holding current value
$41
Previous $70,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.92 - $1.66 $66,921 - $120,750
-72,741 Reduced 99.95%
35 $0
Q2 2025

Aug 14, 2025
BUY
$0.58 - $1.2 $28,522 - $59,012
49,177 Added 208.39%
72,776 $70,000
Q1 2025

May 15, 2025
SELL
$0.52 - $0.9 $8,449 - $14,624
-16,249 Reduced 40.78%
23,599 $16,000
Q4 2024

Feb 13, 2025
BUY
$0.72 - $1.08 $21,686 - $32,529
30,120 Added 309.62%
39,848 $31,000
Q3 2024

Nov 14, 2024
SELL
$0.98 - $1.95 $6,723 - $13,378
-6,861 Reduced 41.36%
9,728 $9,000
Q2 2024

Aug 13, 2024
BUY
$1.18 - $1.98 $2,262 - $3,795
1,917 Added 13.07%
16,589 $25,000
Q1 2024

May 15, 2024
BUY
$0.5 - $1.83 $7,136 - $26,117
14,272 Added 3568.0%
14,672 $24,000
Q4 2023

Feb 13, 2024
SELL
$0.36 - $0.57 $1,450 - $2,296
-4,029 Reduced 90.97%
400 $0
Q3 2023

Nov 14, 2023
SELL
$0.4 - $0.62 $2,564 - $3,974
-6,410 Reduced 59.14%
4,429 $1,000
Q2 2023

Aug 14, 2023
SELL
$0.45 - $0.88 $29,068 - $56,844
-64,596 Reduced 85.63%
10,839 $5,000
Q1 2023

May 09, 2023
BUY
$0.82 - $1.33 $32,327 - $52,433
39,424 Added 109.48%
75,435 $64,000
Q4 2022

Feb 10, 2023
SELL
$1.11 - $1.87 $100,403 - $169,148
-90,454 Reduced 71.52%
36,011 $47,000
Q3 2022

Nov 10, 2022
BUY
$1.75 - $3.1 $99,828 - $176,839
57,045 Added 82.17%
126,465 $225,000
Q2 2022

Aug 15, 2022
BUY
$1.83 - $3.45 $37,866 - $71,387
20,692 Added 42.46%
69,420 $157,000
Q1 2022

May 12, 2022
SELL
$2.34 - $4.72 $45,276 - $91,327
-19,349 Reduced 28.42%
48,728 $161,000
Q4 2021

Feb 14, 2022
BUY
$4.38 - $15.67 $47,632 - $170,411
10,875 Added 19.01%
68,077 $309,000
Q3 2021

Nov 15, 2021
BUY
$6.36 - $8.51 $304,389 - $407,288
47,860 Added 512.31%
57,202 $411,000
Q2 2021

Aug 16, 2021
BUY
$5.52 - $15.68 $44,204 - $125,565
8,008 Added 600.3%
9,342 $75,000
Q1 2021

May 17, 2021
SELL
$1.66 - $15.81 $28,744 - $273,765
-17,316 Reduced 92.85%
1,334 $9,000
Q4 2020

Feb 16, 2021
BUY
$0.28 - $2.6 $5,222 - $48,490
18,650 New
18,650 $34,000

Others Institutions Holding OCGN

# of Institutions
106
Shares Held
60.4M
Call Options Held
531K
Put Options Held
433K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $258M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email